Diagnostic and Therapeutic Technology Assessment (DATTA)

May 1990
JAMA: Journal of the American Medical Association;5/9/90, Vol. 263 Issue 18, p2510
Academic Journal
Discusses the use of aerosolized pentamidine in preventing recurrent Pneumocystis carnii infection in HIV-positive patients. Mechanism of action of the drug; Effectiveness and safety of the drug; Method of delivery of aerosolized pentamidine.


Related Articles

  • Sulfa or Sulfone Prophylaxis and Geographic Region Predict Mutations in the Pneumocystis carinii... Huang, Laurence; Beard, Charles B.; Creasman, Jennifer; Levy, Deborah; Duchin, Jeffrey S.; Lee, Sherline; Pieniazek, Norman; Carter, Jane L.; del Rio, Carlos; Rimland, David; Navin, Thomas R. // Journal of Infectious Diseases;10/1/2000, Vol. 182 Issue 4, p1192 

    Reports on a prospective study of HIV-infected patients with confirmed Pneumocytis carinii pneumonia in three cities in the United States to determine factors associated with mutations in the P. carinii dihydropteroate synthase gene. Significance of geographic location as a risk factor for...

  • 1995 revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children...  // MMWR: Morbidity & Mortality Weekly Report;4/28/95 Supplement RR-4, Vol. 44 Issue 16, p1 

    Presents the revised prevention guidelines for prophylaxis against Pneumocystis carinii pneumonia (PCP) for children infected with or perinatally exposed to human immunodeficiency virus (HIV). Recommendations including the prompt diagnosis of children born to HIV-infected women; Timing and...

  • Clinic HIV-focused features and prevention of Pneumocystis carinii pneumonia. Turner, Barbara J.; Md; Markson, Leona; Cocroft, James; Cosler, Leon; Hauck, Walter W.; Turner; Turner, B J; Markson, L; Cocroft, J; Cosler, L; Hauck, W W // JGIM: Journal of General Internal Medicine;Jan1998, Vol. 13 Issue 1, p16 

    Objective: To examine the association of clinic HIV-focused features and advanced HIV care experience with Pneumocystis carinii pneumonia (PCP) prophylaxis and development of PCP as the initial AIDS diagnosis.Design: Nonconcurrent prospective study.Setting:...

  • Further Promise with AIDS Drug. Helquist, Michael // Advocate;5/10/88, Issue 498, p38 

    Reports on clinical trials of Imreg-I, an anti-AIDS drug. Drug manufacturer Imreg Inc.'s refusal to release study results to the popular press; Ability of the drug to slow or to prevent the development of pneumocystis pneumonia; Stabilization of anemia common to HIV infection.

  • Digital necrosis and disseminated Pneumocystis carinii infection after aerosolized pentamidine prophylaxis. Davey Jr., Richard T.; Margolis, David; Kleiner, David; Deyton, Lawrence; Travis, William; Davey, R T Jr; Margolis, D; Kleiner, D; Deyton, L; Travis, W // Annals of Internal Medicine;10/15/89, Vol. 111 Issue 8, p681 

    Presents cases of patients who developed Pneumocystis carinii pneumonia following aerosolized pentamidine prophylaxis for HIV/AIDS treatment. Medical background of the patients; Treatment administered to the patients; Benefits from aerosolized pentamidine.

  • Pneumocystis carinii pneumonia.  // MMWR: Morbidity & Mortality Weekly Report;6/27/1997 Supplement RR-12, Vol. 46, p4 

    Provides information on the disease pneumocystis carinii pneumonia. Recommendation made by authorities relating to the prevention of exposure to disease; Precautions that should be considered by adolescents, adults and pregnant women.

  • Breathless uncertainty.  // BMJ: British Medical Journal (International Edition);1/21/95, Vol. 310 Issue 6973, p199 

    Reports on how pneumocytis carinii pneumonia affects HIV positive patients. Effects of the disease; Treatment with intravenous cotrimoxazole; Side effect of medication; Living with HIV.

  • Letters to the Editor. May, Todd A.; Gruta, Cristina I.; Goldschmidt, Ronald H. // American Family Physician;10/15/2000, Vol. 62 Issue 8, p1783 

    Reports on the prevalence of pneumocystis carinii pneumonia (PCP) in patients infected with human immunodeficiency virus. Decline of AIDS cases with PCP with the advent of potent antiretroviral therapy.

  • Editorial Response: Do Bacterial Pneumonia and Pneumocystis carinii Pneumonia Accelerate Progression of Human Immunodeficiency Virus Disease? Kaplan, Jonathan E.; Janoff, Edward N.; Masur, Henry // Clinical Infectious Diseases;9/1/1999, Vol. 29 Issue 3, p544 

    Comments on the study by D.H. Osmond and colleagues on the effects of bacterial pneumonia on the progress of HIV in infected persons. Association of the occurrence of bacterial pneumonia and the accelerated progression of the HIV disease; Challenges of preventing bacterial pneumonia among...


Other Topics